Open AccessGastrointestinal Endoscopy in Patients on Direct Oral Anticoagulants. A Consensus Paper of the Romanian Society of Gastroenterology and Hepatology
Author(s) -
Andreea Farcaș,
Simona Bățagă,
C Cijevschi,
Mircea Diculescu,
Daniela Dobru,
Eugen Dumitru,
Adrian Goldiș,
Laurențiu Nedelcu,
Alina Popescu,
Ioan Sporea,
Anca Trifan,
Simona Vălean,
Cristian Gheorghe,
Dan L. Dumitrașcu
Publication year - 2018
Publication title -
journal of gastrointestinal and liver diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.641
H-Index - 48
eISSN - 1842-1121
pISSN - 1841-8724
DOI - 10.15403/jgld.2014.1121.272.end
Subject(s) - medicine , hepatology , endoscopy , intensive care medicine , medline , general surgery , gastroenterology , political science , law
Management of patients undergoing endoscopy and under treatment with the newer direct oral anticoagulants (DOACs) is a common and a complex clinical issue that gastroenterologists have to face more and more often these days. The increasing use of DOACs in patients requiring both short- and long-term anticoagulation is mostly due to the advantages these agents offer, among which the lack of monitoring requirements and the reduced need of dose adjustments are perhaps the most important ones. Managing these patients in the peri-endoscopic period implies balancing the risk for thrombosis that a certain patient carries and the bleeding risk associated with the endoscopic procedure itself. The Romanian Society of Gastroenterology and Hepatology decided to create a consensus paper to serve to practitioners and teachers. After reviewing the available published data and existing recommendations, a Delphi consensus process was carried out involving the leaders of opinion in this field. After reaching expert consensus, we provide herein guidance for a practical approach of DOACs therapy management in patients with endoscopic interventions.